We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Diabetes Trial Guidance Triggers Phase III Review by Roche
Diabetes Trial Guidance Triggers Phase III Review by Roche
February 18, 2009
Roche is reviewing its Phase III development program for investigational diabetes treatment taspoglutide to comply with the FDA’s recent guidance on developing such products.